Further support for active surveillance in the management of low-volume, low-grade prostate cancer.
Albertsen
Peter
P
D000726:Androgen Antagonists / Q000627:therapeutic use*; D001706:Biopsy; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D018579:Patient Selection; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D011788:Quality of Life; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D057832:Watchful Waiting
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen